Eli Lilly Pharmaceuticals: Several products, including Abercillin tablets, have been included in the new national medical insurance catalog
langhu008
发表于 2023-12-13 14:04:07
3916
0
0
On December 13th, Eli Lilly Pharmaceuticals announced that several of its products (including new indications) will be included in the new version of the National Basic Medical Insurance, Work Injury Insurance, and Maternity Insurance Drug Catalogue (2023), including CDK4 in the anti-tumor field; 6 inhibitor selection; Reg; (Abbesili Tablets) HR+, HER2- lymph node positive, high recurrence risk and Ki-67 ≥ 20% early breast cancer adjuvant treatment were included in the medical insurance for the first time, and HR+, HER2- late endocrine sensitivity and late endocrine resistance were successfully renewed; PD-1 inhibitor Dabershu; Reg; New indications for locally advanced or metastatic non-small cell lung cancer with positive EGFR gene mutations that have failed EGFR-TKI treatment have been added to the original medical insurance based on Xindilizumab injection; Immunological IL-17A inhibitor Tuozi& Reg; The indication for plaque psoriasis has been successfully renewed with the addition of indications for ankylosing spondylitis and included in medical insurance; In addition, advanced colorectal cancer drug Aiyoute& Reg; The contract has been successfully renewed for Furoquinib Capsules. The new version of the National Medical Insurance Catalogue will be officially implemented from January 1, 2024.
CandyLake.com 系信息发布平台,仅提供信息存储空间服务。
声明:该文观点仅代表作者本人,本文不代表CandyLake.com立场,且不构成建议,请谨慎对待。
声明:该文观点仅代表作者本人,本文不代表CandyLake.com立场,且不构成建议,请谨慎对待。
猜你喜欢
- Tesla modifies range estimates for multiple models, with Model Y shrinking by nearly 20 miles
- Meta will deploy a new version of self-developed custom chips this year to support AI research and development
- Xiaopeng Motors offers a maximum discount of 50000 yuan on multiple product price reductions
- Lenovo teamed up with Nvidia to launch multiple AI servers with direct water cooling technology targeting the data center market
- Will Smegglutide's indications for treating obesity participate in this year's national medical insurance negotiations? Novo Nordisk responded by stating that they will immediately initiate internet access and hospital admissions in various regions
- Targeting the demand of domestic innovative pharmaceutical companies to "go global", Veeva R&D cloud brings multiple digital products to expand the Chinese market
- New Consumer Daily | Multiple travel platforms respond to a large number of cancellations of accommodation and flight tickets in Japan; Apollo Go denied to carry out business related to investment promotion and franchise
- It is reported that the new version of Amazon Alexa will be mainly supported by Anthropic's AI model
- Technology Weekly | WeChat updates version on Apple iOS system; Taobao clarifies that merchants will gradually open WeChat Pay after September 12th
- Weight loss has become a hot topic at this year's Service Trade Fair: multiple celebrity weight loss drugs appear
-
苹果知名分析师郭明錤周四(10月31日)在社交媒体上发文表示,苹果明年可能会减少对芯片制造商博通Wi-Fi芯片的依赖,并推出自己的处理器。 郭明錤在社交媒体平台X上写道,“在2025年下半年的新产品(例如iPh ...
- uturn
- 前天 14:42
- 支持
- 反对
- 回复
- 收藏
-
10月30日,小鹏汽车生态企业小鹏汇天宣布,旗下分体式飞行汽车“陆地航母”即将亮相2024中国航展,11月12日将在中国航展第二展区(斗门莲洲)进行全球首次公开飞行,同时“陆地航母”也将在珠海国际航展中心8号 ...
- yxtianyouyou
- 3 天前
- 支持
- 反对
- 回复
- 收藏
-
交易所监管文件显示,当地时间11月1日,亚马逊创始人杰夫·贝索斯拟出售约1635万股亚马逊股票,预计套现约30.5亿美元。今年7月,贝索斯已申请额外出售约2500万股亚马逊股票,按当时股价计算可套现约50亿美元。 ...
- blueskybb
- 昨天 09:27
- 支持
- 反对
- 回复
- 收藏
-
近日,凯撒海湾目的地(山东)运营管理有限责任公司(简称“凯撒海湾”)与携程旅悦集团签署战略合作协议,双方将围绕“海上目的地运营”、“旅游产品与服务创新”、“研学旅行”、“日韩及海外旅游市场开拓”等 ...
- llyyy2008
- 昨天 11:01
- 支持
- 反对
- 回复
- 收藏